# Altimmune, Inc.: Form DEF 14A, filed Mar 17, 2026

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: DEF 14A
- Filed: 2026-03-17
- Accepted by EDGAR: Mar 17, 2026, 07:05 ET
- Period: 2026-04-16
- Accession: 0001104659-26-028953
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm

Filed Mar 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-028953. Last ingested by Listed: Nov 4, 2026, 17:05 ET. No prices; not investment advice.